About this trial
Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.
Eligibility criteria
Qualifiers
The study will include patients aged 18-70 years
American Society of Anesthesiologists (ASA) physical status of I or II
Will undergo thoracic, abdominal or spinal surgery
Disqualifiers
cardiac conditions other than hypertension like arrhythmia
previous cardiac surgeries and valvular heart diseases
Trial design
Treatments tested in this trial
- Salbutamol (Ventolin®)
Treatment groups
Locations
1Sponsors and collaborators
King Abdullah University Hospital
Lead sponsor
Jordan University of Science and Technology
Sponsor institution
Jordan University of Science and Technology
Collaborator